Suppr超能文献

鞘内注射肾上腺素对剖宫产麻醉相关结局的影响:我们是否应重新考虑其应用?

Effects of Adding Intrathecal Epinephrine to Spinal Anesthesia on Anesthesia-Related Cesarean Delivery Outcomes: Should We Reconsider Its Use?

作者信息

Rambhia Milly T, DeLeon Alexander M, Bauchat Jeanette, Kenny Eleanor, Cuppini Candice, Lopez Carmen, Samworth Alexander G, Farrer Jason, McCarthy Robert J

机构信息

Anesthesiology, Kaiser Permanente Mid-Atlantic Permanente Medical Group, Rockville, USA.

Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, USA.

出版信息

Cureus. 2023 Sep 13;15(9):e45147. doi: 10.7759/cureus.45147. eCollection 2023 Sep.

Abstract

BACKGROUND

Intrathecal epinephrine is used to increase the duration of spinal anesthesia for amenable surgical procedures anticipated to require additional time; however, in the ambulatory setting, it is associated with a prolonged time to post-anesthesia care unit (PACU) discharge. The current study's authors hypothesized that adding intrathecal epinephrine to spinal anesthesia for cesarean delivery would be associated with a dose-dependent prolonged post-anesthesia unit length of stay.

METHODS

A single-center, retrospective study of patients undergoing repeat cesarean delivery under spinal anesthesia from 2011 to 2015 was conducted. Patients received spinal bupivacaine 12 mg, morphine 150 mcg, and fentanyl 15 mcg with no-epinephrine, 100 mcg, or 200 mcg of epinephrine. The primary outcome was recovery room length of stay. Secondary outcomes were surgical duration, intraoperative vasopressor use, perioperative opioids, and antiemetic use.

RESULTS

Data were analyzed for 1,362 patients. Median recovery room stay was 123 min (interquartile range, 100 to 150) and was not different among groups. More women receiving epinephrine 200 mcg had ≥2 prior cesarean deliveries compared with no-epinephrine or 100 mcg. No significant differences in surgical duration or intraoperative opioids were identified among the groups. Median intraoperative vasopressor use was increased by 225 mcg of phenylephrine equivalents (99% CI, 25 mcg to 430 mcg) in the 100 mcg group and 250 mcg of phenylephrine equivalents in the 200 mcg group (99% CI, 75 mcg to 500 mcg) compared to no-epinephrine (<0.001). Recovery room antiemetic and opioid analgesic administration were not different among groups.

CONCLUSIONS

Based on the results of this study, the addition of intrathecal epinephrine for women undergoing cesarean delivery increases intraoperative vasopressor use but does not prolong PACU length of stay, reduce intraoperative opioids, or increase antiemetic requirements postoperatively. The current study also demonstrated that surgical duration times were not different among the no-epinephrine, 100 mcg, and 200 mcg epinephrine groups.

摘要

背景

鞘内注射肾上腺素用于延长预计需要额外时间的适宜外科手术的脊髓麻醉持续时间;然而,在门诊环境中,它与术后麻醉恢复室(PACU)出院时间延长有关。本研究的作者假设,在剖宫产脊髓麻醉中添加鞘内肾上腺素会导致术后麻醉恢复室住院时间呈剂量依赖性延长。

方法

对2011年至2015年期间接受重复剖宫产脊髓麻醉的患者进行了一项单中心回顾性研究。患者接受12毫克布比卡因、150微克吗啡和15微克芬太尼的脊髓麻醉,分别添加0微克、100微克或200微克肾上腺素。主要结局是恢复室住院时间。次要结局包括手术持续时间、术中血管升压药使用情况、围手术期阿片类药物使用情况和止吐药使用情况。

结果

对1362例患者的数据进行了分析。恢复室中位住院时间为123分钟(四分位间距为100至150分钟),各组之间无差异。与未添加肾上腺素或添加100微克肾上腺素的患者相比,接受200微克肾上腺素的患者中,有更多患者既往有≥2次剖宫产史。各组之间在手术持续时间或术中阿片类药物使用方面未发现显著差异。与未添加肾上腺素组相比,100微克组术中血管升压药的中位使用量增加了相当于225微克去氧肾上腺素(99%CI,25微克至430微克),200微克组增加了相当于250微克去氧肾上腺素(99%CI,75微克至500微克)(<0.001)。各组之间恢复室止吐药和阿片类镇痛药的使用情况无差异。

结论

基于本研究结果,剖宫产妇女鞘内注射肾上腺素会增加术中血管升压药的使用,但不会延长PACU住院时间,不会减少术中阿片类药物的使用,也不会增加术后止吐药的需求。本研究还表明,未添加肾上腺素组、100微克肾上腺素组和200微克肾上腺素组之间的手术持续时间无差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2c6/10498415/27e588bf4b5a/cureus-0015-00000045147-i01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验